Liu, Yingxia
Southern University of Science and Technology · Shenzhen Third People’s Hospital
3 papers on CoChatORCID 0000-0001-6335-3346
Most cited papers
- Verified
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 2,607
- Verified
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 872
- Verified
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology
Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions
Cited by 615
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free